326 related articles for article (PubMed ID: 23515018)
1. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice.
Aso E; Juvés S; Maldonado R; Ferrer I
J Alzheimers Dis; 2013; 35(4):847-58. PubMed ID: 23515018
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
Aso E; Andrés-Benito P; Carmona M; Maldonado R; Ferrer I
J Alzheimers Dis; 2016; 51(2):489-500. PubMed ID: 26890764
[TBL] [Abstract][Full Text] [Related]
3. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
4. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
Cheng Y; Dong Z; Liu S
Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
[TBL] [Abstract][Full Text] [Related]
6. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
7. CB2 cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP/PS1 mice.
Li C; Shi J; Wang B; Li J; Jia H
Neurosci Lett; 2019 Aug; 707():134286. PubMed ID: 31150731
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
9. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
[TBL] [Abstract][Full Text] [Related]
10. CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 mice.
Aso E; Palomer E; Juvés S; Maldonado R; Muñoz FJ; Ferrer I
J Alzheimers Dis; 2012; 30(2):439-59. PubMed ID: 22451318
[TBL] [Abstract][Full Text] [Related]
11. Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.
Qiu H; Zhong R; Liu H; Zhang F; Li S; Le W
J Alzheimers Dis; 2016; 50(3):669-85. PubMed ID: 26757041
[TBL] [Abstract][Full Text] [Related]
12. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.
Martín-Moreno AM; Brera B; Spuch C; Carro E; García-García L; Delgado M; Pozo MA; Innamorato NG; Cuadrado A; de Ceballos ML
J Neuroinflammation; 2012 Jan; 9():8. PubMed ID: 22248049
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats.
Çakır M; Tekin S; Doğanyiğit Z; Erden Y; Soytürk M; Çiğremiş Y; Sandal S
Life Sci; 2019 Jan; 217():25-33. PubMed ID: 30500552
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
15. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
[TBL] [Abstract][Full Text] [Related]
16. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
17. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
Ding Y; Qiao A; Fan GH
Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617
[TBL] [Abstract][Full Text] [Related]
19. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
